Non b'at cura pro sa maladia de Alzheimer, ma b'at paritzas optziones de tratamentu disponìbiles pro agiudare a gestire sos sìntomos e rallentare sa progressione de sa maladia.
Carchi de custos tratamentos includint:
1. Meighinas: b'at paritzas meighinas disponìbiles chi podent agiudare a gestire sos sìntomos de sa maladia de Alzheimer.
Custos includent sos inibidores de sa colinesterasi, comente a su donepezilu, sa rivastigmina e sa galantamina, chi podent agiudare a megiorare sa funtzione cognitiva e sa memòria.
Sa memantina est un"àteru meighinu chi podet agiudare cun sa funtzione cognitiva e sos sìntomos cumportamentales.
2. Cambiamentos in su modu de bìvere: fàghere esertzìtzios fìsicos regulare, mandigare bene e mantènnere unu cuntatu sotziale podet agiudare a megiorare sa salude e su benèssere de sas persones cun maladia de Alzheimer.
3. Teràpias cognitivas e cumportamentales: sas terapias cognitivas, comente sa terapia de istimulatzione cognitiva, podent agiudare a megiorare sa funtzione cognitiva e sa memòria in sas persones cun maladia de Alzheimer.
Sas terapias cumportamentales, comente sa terapia cumportamentale cognitiva, podent agiudare a gestire sos sìntomos cumportamentales e megiorare sa calidade de sa vida.
4. Curas de suportu: Curas de suportu, comente a terapia ocupazionale, terapia de su limbàgiu e terapia fìsica, podent agiudare sas persones cun sa maladia de Alzheimer a mantènnere s'indipendèntzia e funtzionare su prus a longu possìbile.
5. Isperimentatziones clìnicas: Partetzipare a sas proas clìnicas pro tratamentos e terapias noas podet frunire atzessu a tratamentos de ùrtima generatzione e agiudare a contribuire a s'isvilupu de tratamentos noos pro sa maladia de Alzheimer.
Est de importu a traballare in manera istrinta cun unu dotore pro isvilupare unu pranu de tratamentu individualizadu pro sa maladia de Alzheimer, ca sos bisòngios e sos sìntomos de cada persone podent variare.
In prus, est essentziale frunire suportu e cura emozionale siat pro sa persone cun sa maladia de Alzheimer siat pro sos badantes issoro.
Kumar A, Singh A, Aggarwal A: Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview. Indian J Exp Biol. 2017, 55 (2): 63-73.
Sutor B, Rasmussen KG: Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT. 2008, 24 (3): 239-41.
Boada M, Ramos-Fernández E, Guivernau B, Muñoz FJ, Costa M, Ortiz AM, Jorquera JI, Núñez L, Torres M, Páez A: Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study. Neurologia. 2016, 31 (7): 473-81.
Golde TE: The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol. 2005, 15 (1): 84-7.
Giacobini E: Therapy of Alzheimer disease: symptomatic or neuroprotective? J Neural Transm Suppl. 1994, 43 (): 211-7.
Haussmann R, Donix M: [Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]. Nervenarzt. 2017, 88 (1): 40-45.
['Disclaimer: mèdicu']
['Custu giassu est fatu po istudiare e informae sa zente e non est unu giassu de consultatzione o de azudu.']
['Sa informassione frunida no est de impreare pro diagnosticare o curare unu problema de salude o una maladia, e sos chi chircant consìgios mèdicos personales si depent cuntatare cun unu mèdicu autorizadu.']
["S'arricordaus ca sa retza neurali chi creat rispostas a is pregontas est imperfeta candu si chistionat de nùmerus, po nai su nùmeru de personas chi tenint una maladia."]
["Chirca semper su parre de su dotore tuo o de un'àteru dotore cualificadu pro cale si siat cunditzione mèiga. No disconnoscas mai su parre de unu professionista mèigu o non bi tardes a l'agatare pro carchi cosa chi as lèghidu in custu situ. Si tenes pensamentos de tènnere un'emergèntzia mèiga, telefona a su 911 o bae a su pronto soccorsu prus acanta."]
['Disclaimer: deretu de autore']
['Sa Digital Millennium Copyright Act de su 1998, 17 U.S.C. § 512 (sa DMCA) donat unu recursu a is propietàrius de deretus de autori chi pensant chi unu materiali chi aparit in Internet ofendet is deretus insoru assuta de sa lei de su deretu de autori de is IUA. ']
["Si creis de bona fidi chi calicunu cuntènniu o materiale postu a disponimentu in su giassu o in is servìtzios nostros at ofesu is deretus de autore tuos, tui (o s'agenti tuo) nos podes imbiare una comunicatzioni domandendi de nde bogare su cuntènniu o su materiale, o de nde blocare s'atzessu."]
['Sos annùntzios depent èssere imbiados pro iscrittu pro mèdiu de posta eletrònica (càstia sa setzione "Cuntatu" pro s\'indiritzu de posta eletrònica). ']
["Sa DMCA recheret chi sa notìfica tua de sa presunta violatzione de copyright incluat sas informatziones sighentes: (1) descritzione de s'òpera amparada dae copyright chi est ogetu de sa presunta violatzione; (2) descritzione de su chi si narat chi est unu cuntènnidu chi diat pòdere èssere istadu violadu e informatziones bastantes pro nos permìtere de localizare su cuntènnidu; (3) informatziones pro ti cuntatare, intre cales s'indiritzu tuo, su nùmeru de telèfono e s'indiritzu de posta eletrònica; (4) una decraratzione tua pro nàrrere chi tenes bona fide chi su cuntènnidu de sa manera chi ses lamentende non est autorizadu dae su mere de su copyright, dae s'agente suo o dae cale si siat lege."]
["5) una decraratzione firma tua, suta pena de perjuria, chi is informatziones in sa notìfica sunt acuradas e chi tenes s'autorizatzione pro aplicare is deretos de autore chi sunt istados violados; "]
['e (6) una firma fìsica o eletrònica de su mere de su deretu de autore o de una persone autorizada a agire a nùmene suo. ']
['Si non ponis totu is informatzionis de prima podit essi chi su protzedimentu ti siat tardau.']
['Contatu']
['Manda·nos una mail cun cale si siat dimanda o sugerimentu.']
How to treat alzheimer?
There is no cure for Alzheimer's disease, but there are several treatment options available to help manage the symptoms and slow the progression of the disease.
Some of these treatments include:
1. Medications: There are several medications available that can help manage the symptoms of Alzheimer's disease.
These include cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, which can help improve cognitive function and memory.
Memantine is another medication that can help with cognitive function and behavioral symptoms.
2. Lifestyle changes: Engaging in regular physical exercise, eating a healthy diet, and maintaining social connections can help improve overall health and well-being for people with Alzheimer's disease.
3. Cognitive and behavioral therapies: Cognitive therapies, such as cognitive stimulation therapy, can help improve cognitive function and memory in people with Alzheimer's disease.
Behavioral therapies, such as cognitive behavioral therapy, can help manage behavioral symptoms and improve quality of life.
4. Supportive care: Supportive care, such as occupational therapy, speech therapy, and physical therapy, can help people with Alzheimer's disease maintain their independence and function as long as possible.
5. Clinical trials: Participating in clinical trials for new treatments and therapies can provide access to cutting-edge treatments and help contribute to the development of new treatments for Alzheimer's disease.
It is important to work closely with a healthcare provider to develop an individualized treatment plan for Alzheimer's disease, as the needs and symptoms of each person can vary.
Additionally, it is essential to provide emotional support and care for both the person with Alzheimer's disease and their caregivers.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Prus o mancu']
['BioMedLib impreat elaboradores automatizados (algoritmos de imparu automàticu) pro generare parigas de dimandas e rispostas.']
['Incumentzamus cun 35 milliones de publicatziones biomèdicas de PubMed/Medline. E puru, pàginas web de RefinedWeb.']
